Hearing Details Public Health Effects of Xylazine

Event Details

Status:

Completed

Event Date:

Thursday, October 9, 2025

Start Time:

10:00 AM

Location:

B-1 and Virtual

Virtual Hearing

Event Description

Special Commission on Xylazine

The second public meeting of the Special Commission on Xylazine, established by Chapter 285 of the Acts of 2024, will take place on Thursday, October 9, 2025 from 10:00am - 2:00pm virtually via Microsoft Teams.

This virtual meeting will be streamed live on the https://malegislature.gov/ webpage.

Meeting Agenda

Welcome and attendance
Approve Minutes of the June 23, 2025 Public Meeting
Updates on the Commission and working groups
Public Comment
Next Steps and Discussion

Please be advised that the schedule, agenda, and format of the meeting are subject to change at the discretion of the Chairs.

You may contact Commission staff with any questions by email at Lily.Stowe-Alekman@mahouse.gov and Gabe.Adams-Keane@masenate.gov.

INSTRUCTIONS FOR PUBLIC COMMENT REGISTRATION / TESTIMONY
The public is invited to participate in this virtual public meeting of the Special Commission on Xylazine, which will be streamed live and archived on the General Court website, https://malegislature.gov/

All persons who wish to testify are strongly encouraged to sign up in advance by completing this form: https://forms.office.com/g/TkZnhHd0VF

Further instructions will be sent to those who register to testify virtually. The Commission will provide a link to join the public meeting to those who sign up to testify virtually via Microsoft Teams.

Individuals who do not pre-register to speak may email gabe.adams-keane@masenate.gov or may appear on the day of the public meeting outside Hearing Room B1 to receive assistance by Commission staff to join the meeting virtually. When all pre-registered individuals have been called to testify, the presiding Chair will then call any individuals who sign-up on the day of the public meeting.

LEGISLATOR AND PUBLIC OFFICIAL TESTIMONY

Legislators and public officials are also required to pre-register to testify virtually. The presiding Chair, at their discretion, may take legislators and public officials out of turn. The Commission will extend this courtesy to legislators and public officials only, and it will not be expanded to include other individuals or panels.

ORAL TESTIMONY - TIME LIMIT:

Each individual registered to testify shall be afforded 3 minutes to speak. The presiding Chair, at their discretion, may further limit the time for testimony.

ORAL TESTIMONY – PARTICIPATING AS A PANEL
Each individual participating as part of a panel must fill out the pre-registration form separately and completely. Each member of a panel must fill out the appropriate section of the pre-registration form indicating that they will be participating as part of a panel. The presiding Chair will permit fully remote panels only.

ORDER OF TESTIMONY:

The presiding Chair, at their discretion, will determine the order of testimony during the course of the public meeting. It is the responsibility of the individuals registered to testify to be prepared to speak when called upon by the presiding Chair. In the event that an individual testifying is called by the presiding Chair and that person is not logged into the Teams platform , the presiding Chair will move on and call the next individual or panel.

WRITTEN TESTIMONY – DO NOT FILL OUT THE FORM
For individuals wishing to provide written testimony ONLY, please do not fill out this form. Written testimony is encouraged and will continue to be accepted after the public meeting. Written testimony may be submitted electronically via e-mail to the following: gabe.adams-keane@masenate.gov and Lily.Stowe-Alekman@mahouse.gov.

For testimony submitted by email, please include the “XYLAZINE COMMISSION TESTIMONY” in the subject line of the email, as well as your name, address, phone number, and organization, if any, on the submitted testimony. Registration is not required to submit written testimony.

Written testimony may be physically mailed to the House and Senate Chairs at the below addresses:

CHAIR MINDY DOMB

SPECIAL COMMISSION ON XYLAZINE

ATTN: LILY STOWE-ALEKMAN

24 BEACON STREET, ROOM 33

BOSTON MA, 02133

CHAIR JOHN C. VELIS

SPECIAL COMMISSION ON XYLAZINE

ATTN: GABE ADAMS-KEANE

24 BEACON STREET, ROOM 513

BOSTON MA, 02133

Those who do not plan to testify but want to watch the public meeting may view the live stream under the Hearings & Events section of the legislative website.

ACCESSIBILITY ACCOMMODATIONS:

The Commission will work to coordinate reasonable accommodations required to ensure that people with disabilities are able to participate fully in the public meeting process. Timely requests for accessibility accommodations, such as assistive listening devices and systems, sign language interpreting services, closed captioning and transcription services, will be provided upon request. Requests for services should be submitted by completing the state house accessibility form, https://malegislature.gov/StateHouse/AccessibilityForm/.

Questions regarding this public meeting should be directed to Senate Chair Velis' office by contacting Chief of Staff Gabe Adams-Keane at gabe.adams-keane@masenate.gov

Updated: October 7, 2025 at 10:50 A.M.

Videos
Item Name	Start Time	Duration	Webcast
Public Health Effects of Xylazine -10-9-2025	10/9/2025 10:00 AM	01:29:21

Documents
	Document
	Approved - 6.23.25 XC Meeting Minutes

Bills

General Laws

Session Laws

Massachusetts Constitution

Senate Journals

House Journals

Rules

Reports and Communications

Drafting Manual

Glossary

Legislators

Legislative Leadership

Senate

House

Dockets

Senate Clerk

House Clerk

Senate Audits

Senate Journals

House Audits

House Journals

All Hearings & Events

Sessions

Hearings

Special Events

All Committees

Committees

Committee Hearings

Commissions

Committee Book

Hearing Attendance

Visit the State House

Accessibility

Educational Opportunities

Create Your Own Bill

Media Gallery

FAQ

Contact Us

Hearing Details Public Health Effects of Xylazine

Hearing Details Public Health Effects of Xylazine

Search the Legislature